Crossmark Global Holdings, Inc. Natera, Inc. Transaction History

Crossmark Global Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $5,820 - $9,709	155 Added 2.18%	7,267 $456,000
Q3 2023 Nov 08, 2023	BUY	$43.4 - $62.52 $18,358 - $26,445	423 Added 6.32%	7,112 $326,000
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $475 - $757	13 Added 0.19%	6,689 $371,000
Q4 2022 Jan 19, 2023	BUY	$34.17 - $47.91 $20,502 - $28,745	600 Added 9.87%	6,676 $268,000
Q3 2022 Nov 01, 2022	SELL	$36.93 - $56.68 $6,167 - $9,465	-167 Reduced 2.67%	6,076 $266,000
Q2 2022 Jul 29, 2022	BUY	$28.13 - $44.54 $5,710 - $9,041	203 Added 3.36%	6,243 $221,000
Q1 2022 May 11, 2022	BUY	$30.32 - $91.33 $183,132 - $551,633	6,040 New	6,040 $246,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.